25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

UCB (Ucb) Stock Analysis
Buy, Hold or Sell?

Let's analyze Ucb together

I guess you are interested in UCB SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Ucb’s Financial Insights
  • 📈 Technical Analysis (TA) – Ucb’s Price Targets

I'm going to help you getting a better view of UCB SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about UCB SA

I send you an email if I find something interesting about UCB SA.

1. Quick Overview

1.1. Quick analysis of Ucb (30 sec.)










1.2. What can you expect buying and holding a share of Ucb? (30 sec.)

How much money do you get?

How much money do you get?
€6.21
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€51.43
Expected worth in 1 year
€73.22
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
€27.10
Return On Investment
15.9%

For what price can you sell your share?

Current Price per Share
€170.95
Expected price per share
€152.95 - €193.76
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ucb (5 min.)




Live pricePrice per Share (EOD)
€170.95
Intrinsic Value Per Share
€16.88 - €48.79
Total Value Per Share
€68.30 - €100.22

2.2. Growth of Ucb (5 min.)




Is Ucb growing?

Current yearPrevious yearGrowGrow %
How rich?$11.7b$10.4b$1.2b10.5%

How much money is Ucb making?

Current yearPrevious yearGrowGrow %
Making money$1.2b$401m$844.1m67.8%
Net Profit Margin17.3%6.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Ucb (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#11 / 872

Most Revenue
#3 / 872

Most Profit
#4 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ucb?

Welcome investor! Ucb's management wants to use your money to grow the business. In return you get a share of Ucb.

First you should know what it really means to hold a share of Ucb. And how you can make/lose money.

Speculation

The Price per Share of Ucb is €170.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ucb.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ucb, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €51.43. Based on the TTM, the Book Value Change Per Share is €5.45 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €1.33 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ucb.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps6.393.7%6.393.7%2.051.2%3.652.1%4.352.5%4.312.5%
Usd Book Value Change Per Share6.373.7%6.373.7%-0.63-0.4%3.211.9%3.402.0%3.011.8%
Usd Dividend Per Share1.550.9%1.550.9%1.510.9%1.510.9%1.480.9%1.430.8%
Usd Total Gains Per Share7.924.6%7.924.6%0.880.5%4.732.8%4.882.9%4.442.6%
Usd Price Per Share224.72-224.72-92.25-134.33-123.82-103.12-
Price to Earnings Ratio35.19-35.19-44.90-38.13-31.04-25.38-
Price-to-Total Gains Ratio28.36-28.36-105.17-49.84-42.34-34.16-
Price to Book Ratio3.74-3.74-1.72-2.34-2.32-2.29-
Price-to-Total Gains Ratio28.36-28.36-105.17-49.84-42.34-34.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share199.87474
Number of shares5
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.551.48
Usd Book Value Change Per Share6.373.40
Usd Total Gains Per Share7.924.88
Gains per Quarter (5 shares)39.6124.41
Gains per Year (5 shares)158.4597.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
131127148306888
26225530659136186
39338246489204284
4124510622118272382
5155637780148340480
6186764938178408578
72178921096207476676
824810191254237544774
928011471412267612872
1031112741570296680970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.02.092.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%19.06.00.076.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.03.00.088.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of UCB SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.4485.4480%-0.541+110%2.747+98%2.909+87%2.575+112%
Book Value Per Share--51.42951.4290%45.981+12%47.977+7%44.911+15%38.223+35%
Current Ratio--1.3571.3570%1.317+3%1.245+9%1.264+7%1.233+10%
Debt To Asset Ratio--0.4220.4220%0.4220%0.424-1%0.427-1%0.429-2%
Debt To Equity Ratio--0.7300.7300%0.7310%0.737-1%0.748-2%0.751-3%
Dividend Per Share--1.3281.3280%1.291+3%1.296+3%1.267+5%1.223+9%
Enterprise Value--31919427853.80031919427853.8000%9805491000.000+226%16773969297.933+90%15417077488.760+107%12729778248.380+151%
Eps--5.4615.4610%1.757+211%3.121+75%3.716+47%3.690+48%
Ev To Ebitda Ratio--16.26116.2610%7.685+112%10.437+56%9.953+63%9.410+73%
Ev To Sales Ratio--5.1885.1880%1.867+178%2.871+81%2.682+93%2.488+109%
Free Cash Flow Per Share--4.7184.7180%2.280+107%3.612+31%4.013+18%3.534+34%
Free Cash Flow To Equity Per Share--0.5230.5230%0.702-25%1.808-71%2.989-83%1.352-61%
Gross Profit Margin---0.948-0.9480%-3.647+285%-2.386+152%-1.620+71%-1.218+28%
Intrinsic Value_10Y_max--48.791----------
Intrinsic Value_10Y_min--16.875----------
Intrinsic Value_1Y_max--4.211----------
Intrinsic Value_1Y_min--3.100----------
Intrinsic Value_3Y_max--13.170----------
Intrinsic Value_3Y_min--8.150----------
Intrinsic Value_5Y_max--22.751----------
Intrinsic Value_5Y_min--11.884----------
Market Cap32487679900.000-15%37480427853.80037480427853.8000%15400491000.000+143%22404302631.267+67%20621677488.760+82%17027178248.380+120%
Net Profit Margin--0.1730.1730%0.065+165%0.105+65%0.127+36%0.133+30%
Operating Margin--0.2150.2150%0.111+93%0.144+49%0.166+30%0.186+16%
Operating Ratio--0.7850.7850%0.885-11%0.866-9%0.843-7%0.821-4%
Pb Ratio3.324-12%3.7373.7370%1.716+118%2.345+59%2.323+61%2.289+63%
Pe Ratio31.302-12%35.19335.1930%44.899-22%38.126-8%31.043+13%25.379+39%
Price Per Share170.950-12%192.200192.2000%78.900+144%114.887+67%105.898+81%88.201+118%
Price To Free Cash Flow Ratio36.235-12%40.74040.7400%34.608+18%31.503+29%27.062+51%31.469+29%
Price To Total Gains Ratio25.228-12%28.36428.3640%105.167-73%49.839-43%42.345-33%34.160-17%
Quick Ratio--0.9210.9210%0.847+9%0.829+11%0.884+4%0.887+4%
Return On Assets--0.0610.0610%0.022+178%0.037+68%0.048+28%0.054+14%
Return On Equity--0.1060.1060%0.038+178%0.064+67%0.083+27%0.093+15%
Total Gains Per Share--6.7766.7760%0.750+803%4.043+68%4.176+62%3.798+78%
Usd Book Value--11725906800.00011725906800.0000%10493570000.000+12%10939035200.000+7%10224887840.000+15%8622733080.000+36%
Usd Book Value Change Per Share--6.3706.3700%-0.632+110%3.212+98%3.402+87%3.011+112%
Usd Book Value Per Share--60.13160.1310%53.761+12%56.095+7%52.510+15%44.690+35%
Usd Dividend Per Share--1.5531.5530%1.509+3%1.515+3%1.481+5%1.430+9%
Usd Enterprise Value--37320195046.66337320195046.6630%11464580077.200+226%19612124903.144+90%18025646999.858+107%14883656728.006+151%
Usd Eps--6.3856.3850%2.055+211%3.649+75%4.345+47%4.314+48%
Usd Free Cash Flow--1075664000.0001075664000.0000%520294000.000+107%823506533.333+31%913145200.000+18%796108280.000+35%
Usd Free Cash Flow Per Share--5.5165.5160%2.666+107%4.223+31%4.692+18%4.131+34%
Usd Free Cash Flow To Equity Per Share--0.6120.6120%0.821-25%2.114-71%3.495-83%1.580-61%
Usd Market Cap37984595339.080-15%43822116246.66343822116246.6630%18006254077.200+143%26195110636.477+67%24110865319.858+82%19908176808.006+120%
Usd Price Per Share199.875-12%224.720224.7200%92.250+144%134.325+67%123.816+81%103.125+118%
Usd Profit--1245198000.0001245198000.0000%401035600.000+210%711653066.667+75%845565440.000+47%788625400.000+58%
Usd Revenue--7192918400.0007192918400.0000%6140638400.000+17%6594677733.333+9%6558042800.000+10%5856172040.000+23%
Usd Total Gains Per Share--7.9237.9230%0.877+803%4.727+68%4.883+62%4.441+78%
 EOD+4 -4MRQTTM+0 -0YOY+34 -63Y+34 -65Y+33 -710Y+33 -7

3.3 Fundamental Score

Let's check the fundamental score of UCB SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.302
Price to Book Ratio (EOD)Between0-13.324
Net Profit Margin (MRQ)Greater than00.173
Operating Margin (MRQ)Greater than00.215
Quick Ratio (MRQ)Greater than10.921
Current Ratio (MRQ)Greater than11.357
Debt to Asset Ratio (MRQ)Less than10.422
Debt to Equity Ratio (MRQ)Less than10.730
Return on Equity (MRQ)Greater than0.150.106
Return on Assets (MRQ)Greater than0.050.061
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of UCB SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.130
Ma 20Greater thanMa 50165.745
Ma 50Greater thanMa 100162.050
Ma 100Greater thanMa 200164.228
OpenGreater thanClose172.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About UCB SA

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF-mediated diseases, as well as ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; and Neupro for Parkinson's disease and restless legs syndrome. It also provides Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. In addition, the company offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx to treat plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; Fintepla for the treatment of Dravet/Lennox-Gastaut syndrome; and RYSTIGGO and ZILBRYSQ to treat people living with generalized myasthenia gravis. Further, it develops doxecitine/doxribtimine for TK2 deficiency disorder; fenfluramine to treat CDKL5 deficiency disorder; dapirolizumab pegol for systemic lupus erythematosus; STACCATO alprazolam for treating stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; UCB0222 for the treatment of Parkinson's disease; and UCB9741 and UCB1381 for atopic dermatitis. Additionally, it engages in the contract manufacturing activities. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Fundamental data was last updated by Penke on 2025-07-09 16:49:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ucb earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • A Net Profit Margin of 17.3% means that €0.17 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of UCB SA:

  • The MRQ is 17.3%. The company is making a huge profit. +2
  • The TTM is 17.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.3%TTM17.3%0.0%
TTM17.3%YOY6.5%+10.8%
TTM17.3%5Y12.7%+4.6%
5Y12.7%10Y13.3%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.3%-91.7%+109.0%
TTM17.3%-140.3%+157.6%
YOY6.5%-196.4%+202.9%
3Y10.5%-247.9%+258.4%
5Y12.7%-343.3%+356.0%
10Y13.3%-488.1%+501.4%
4.3.1.2. Return on Assets

Shows how efficient Ucb is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • 6.1% Return on Assets means that Ucb generated €0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of UCB SA:

  • The MRQ is 6.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.1%0.0%
TTM6.1%YOY2.2%+3.9%
TTM6.1%5Y4.8%+1.4%
5Y4.8%10Y5.4%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%-11.5%+17.6%
TTM6.1%-11.5%+17.6%
YOY2.2%-11.4%+13.6%
3Y3.7%-11.7%+15.4%
5Y4.8%-11.9%+16.7%
10Y5.4%-13.7%+19.1%
4.3.1.3. Return on Equity

Shows how efficient Ucb is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • 10.6% Return on Equity means Ucb generated €0.11 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of UCB SA:

  • The MRQ is 10.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.6%TTM10.6%0.0%
TTM10.6%YOY3.8%+6.8%
TTM10.6%5Y8.3%+2.3%
5Y8.3%10Y9.3%-0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6%-13.6%+24.2%
TTM10.6%-14.8%+25.4%
YOY3.8%-14.4%+18.2%
3Y6.4%-16.8%+23.2%
5Y8.3%-17.5%+25.8%
10Y9.3%-19.5%+28.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of UCB SA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ucb is operating .

  • Measures how much profit Ucb makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • An Operating Margin of 21.5% means the company generated €0.21  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of UCB SA:

  • The MRQ is 21.5%. The company is operating efficient. +1
  • The TTM is 21.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.5%TTM21.5%0.0%
TTM21.5%YOY11.1%+10.4%
TTM21.5%5Y16.6%+4.9%
5Y16.6%10Y18.6%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.5%-221.8%+243.3%
TTM21.5%-250.7%+272.2%
YOY11.1%-208.5%+219.6%
3Y14.4%-220.2%+234.6%
5Y16.6%-342.4%+359.0%
10Y18.6%-462.5%+481.1%
4.3.2.2. Operating Ratio

Measures how efficient Ucb is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are €0.78 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of UCB SA:

  • The MRQ is 0.785. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.785. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.785TTM0.7850.000
TTM0.785YOY0.885-0.100
TTM0.7855Y0.843-0.058
5Y0.84310Y0.821+0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7852.097-1.312
TTM0.7852.684-1.899
YOY0.8853.076-2.191
3Y0.8663.524-2.658
5Y0.8434.724-3.881
10Y0.8216.445-5.624
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of UCB SA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ucb is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.36 means the company has €1.36 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of UCB SA:

  • The MRQ is 1.357. The company is just able to pay all its short-term debts.
  • The TTM is 1.357. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.357TTM1.3570.000
TTM1.357YOY1.317+0.040
TTM1.3575Y1.264+0.092
5Y1.26410Y1.233+0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3573.638-2.281
TTM1.3573.846-2.489
YOY1.3174.140-2.823
3Y1.2454.688-3.443
5Y1.2645.722-4.458
10Y1.2336.144-4.911
4.4.3.2. Quick Ratio

Measures if Ucb is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • A Quick Ratio of 0.92 means the company can pay off €0.92 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of UCB SA:

  • The MRQ is 0.921. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.921. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.921TTM0.9210.000
TTM0.921YOY0.847+0.074
TTM0.9215Y0.884+0.038
5Y0.88410Y0.887-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9212.826-1.905
TTM0.9213.116-2.195
YOY0.8473.786-2.939
3Y0.8294.311-3.482
5Y0.8845.702-4.818
10Y0.8876.335-5.448
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of UCB SA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ucb assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ucb to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.42 means that Ucb assets are financed with 42.2% credit (debt) and the remaining percentage (100% - 42.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of UCB SA:

  • The MRQ is 0.422. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.422. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.422TTM0.4220.000
TTM0.422YOY0.422-0.001
TTM0.4225Y0.427-0.006
5Y0.42710Y0.429-0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4220.327+0.095
TTM0.4220.349+0.073
YOY0.4220.332+0.090
3Y0.4240.340+0.084
5Y0.4270.346+0.081
10Y0.4290.378+0.051
4.5.4.2. Debt to Equity Ratio

Measures if Ucb is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • A Debt to Equity ratio of 73.0% means that company has €0.73 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of UCB SA:

  • The MRQ is 0.730. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.730. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.730TTM0.7300.000
TTM0.730YOY0.731-0.002
TTM0.7305Y0.748-0.018
5Y0.74810Y0.751-0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7300.383+0.347
TTM0.7300.438+0.292
YOY0.7310.414+0.317
3Y0.7370.450+0.287
5Y0.7480.457+0.291
10Y0.7510.512+0.239
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Ucb generates.

  • Above 15 is considered overpriced but always compare Ucb to the Biotechnology industry mean.
  • A PE ratio of 35.19 means the investor is paying €35.19 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of UCB SA:

  • The EOD is 31.302. Based on the earnings, the company is overpriced. -1
  • The MRQ is 35.193. Based on the earnings, the company is overpriced. -1
  • The TTM is 35.193. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD31.302MRQ35.193-3.891
MRQ35.193TTM35.1930.000
TTM35.193YOY44.899-9.707
TTM35.1935Y31.043+4.150
5Y31.04310Y25.379+5.664
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD31.302-2.399+33.701
MRQ35.193-2.092+37.285
TTM35.193-2.625+37.818
YOY44.899-3.784+48.683
3Y38.126-3.762+41.888
5Y31.043-6.363+37.406
10Y25.379-7.055+32.434
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of UCB SA:

  • The EOD is 36.235. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 40.740. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 40.740. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD36.235MRQ40.740-4.504
MRQ40.740TTM40.7400.000
TTM40.740YOY34.608+6.132
TTM40.7405Y27.062+13.678
5Y27.06210Y31.469-4.407
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD36.235-3.299+39.534
MRQ40.740-2.742+43.482
TTM40.740-3.801+44.541
YOY34.608-4.402+39.010
3Y31.503-5.140+36.643
5Y27.062-8.483+35.545
10Y31.469-9.296+40.765
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ucb is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.74 means the investor is paying €3.74 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of UCB SA:

  • The EOD is 3.324. Based on the equity, the company is fair priced.
  • The MRQ is 3.737. Based on the equity, the company is fair priced.
  • The TTM is 3.737. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.324MRQ3.737-0.413
MRQ3.737TTM3.7370.000
TTM3.737YOY1.716+2.021
TTM3.7375Y2.323+1.414
5Y2.32310Y2.289+0.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.3242.113+1.211
MRQ3.7371.856+1.881
TTM3.7372.125+1.612
YOY1.7162.454-0.738
3Y2.3452.492-0.147
5Y2.3233.668-1.345
10Y2.2894.364-2.075
4.6.2. Total Gains per Share

2.4. Latest News of UCB SA

Does UCB SA still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from UCB SA to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-17
14:22
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.Read
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets17,347,000
Total Liabilities7,318,000
Total Stockholder Equity10,029,000
 As reported
Total Liabilities 7,318,000
Total Stockholder Equity+ 10,029,000
Total Assets = 17,347,000

Assets

Total Assets17,347,000
Total Current Assets4,788,000
Long-term Assets12,559,000
Total Current Assets
Cash And Cash Equivalents 1,573,000
Short-term Investments 184,000
Net Receivables 1,310,000
Inventory 1,309,000
Other Current Assets 412,000
Total Current Assets  (as reported)4,788,000
Total Current Assets  (calculated)4,788,000
+/-0
Long-term Assets
Property Plant Equipment 1,754,000
Goodwill 5,462,000
Intangible Assets 4,082,000
Long-term Assets Other 277,000
Long-term Assets  (as reported)12,559,000
Long-term Assets  (calculated)11,575,000
+/- 984,000

Liabilities & Shareholders' Equity

Total Current Liabilities3,529,000
Long-term Liabilities3,789,000
Total Stockholder Equity10,029,000
Total Current Liabilities
Short-term Debt 63,000
Short Long Term Debt 2,000
Accounts payable 750,000
Other Current Liabilities 2,552,000
Total Current Liabilities  (as reported)3,529,000
Total Current Liabilities  (calculated)3,367,000
+/- 162,000
Long-term Liabilities
Long term Debt 2,818,000
Capital Lease Obligations 206,000
Long-term Liabilities Other 1,000
Long-term Liabilities  (as reported)3,789,000
Long-term Liabilities  (calculated)3,025,000
+/- 764,000
Total Stockholder Equity
Common Stock584,000
Retained Earnings 7,395,000
Other Stockholders Equity 2,050,000
Total Stockholder Equity (as reported)10,029,000
Total Stockholder Equity (calculated)10,029,000
+/-0
Other
Capital Stock584,000
Cash and Short Term Investments 1,757,000
Common Stock Shares Outstanding 195,007
Liabilities and Stockholders Equity 17,347,000
Net Debt 1,453,000
Net Invested Capital 12,849,000
Net Working Capital 1,259,000
Property Plant and Equipment Gross 3,225,000
Short Long Term Debt Total 3,026,000



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
2,303,136
2,563,854
2,620,935
3,090,935
5,373,540
4,717,000
10,498,000
9,555,000
9,524,000
9,120,000
8,969,000
9,178,000
9,360,000
9,760,000
10,148,000
10,956,000
10,212,000
9,917,000
10,514,000
11,081,000
13,319,000
14,210,000
15,868,000
15,539,000
17,347,000
17,347,00015,539,00015,868,00014,210,00013,319,00011,081,00010,514,0009,917,00010,212,00010,956,00010,148,0009,760,0009,360,0009,178,0008,969,0009,120,0009,524,0009,555,00010,498,0004,717,0005,373,5403,090,9352,620,9352,563,8542,303,136
   > Total Current Assets 
0
0
1,731,644
1,789,831
1,911,978
1,303,000
2,355,000
1,655,000
1,837,000
1,794,000
1,731,000
1,706,000
1,822,000
2,424,000
2,501,000
2,838,000
2,331,000
2,677,000
2,950,000
3,295,000
3,582,000
3,710,000
3,304,000
3,444,000
4,788,000
4,788,0003,444,0003,304,0003,710,0003,582,0003,295,0002,950,0002,677,0002,331,0002,838,0002,501,0002,424,0001,822,0001,706,0001,731,0001,794,0001,837,0001,655,0002,355,0001,303,0001,911,9781,789,8311,731,64400
       Cash And Cash Equivalents 
109,031
88,782
482,376
449,199
148,369
424,000
974,000
479,000
463,000
486,000
494,000
267,000
318,000
750,000
507,000
1,285,000
761,000
1,049,000
1,262,000
329,000
662,000
1,263,000
899,000
861,000
1,573,000
1,573,000861,000899,0001,263,000662,000329,0001,262,0001,049,000761,0001,285,000507,000750,000318,000267,000494,000486,000463,000479,000974,000424,000148,369449,199482,37688,782109,031
       Short-term Investments 
266,929
339,054
420,732
359,051
400,359
0
0
96,000
3,000
53,000
61,000
38,000
8,000
1,000
1,000
34,000
46,000
14,000
17,000
989,000
704,000
110,000
170,000
108,000
184,000
184,000108,000170,000110,000704,000989,00017,00014,00046,00034,0001,0001,0008,00038,00061,00053,0003,00096,00000400,359359,051420,732339,054266,929
       Net Receivables 
741,773
822,046
438,545
903,218
681,000
544,000
826,000
868,000
835,000
806,000
690,000
818,000
798,000
919,000
675,000
804,000
820,000
738,000
632,000
707,000
760,000
1,134,000
993,000
1,140,000
1,310,000
1,310,0001,140,000993,0001,134,000760,000707,000632,000738,000820,000804,000675,000919,000798,000818,000690,000806,000835,000868,000826,000544,000681,000903,218438,545822,046741,773
       Other Current Assets 
44,898
27,990
833,659
33,468
51,000
63,000
61,000
1,000
72,000
44,000
52,000
46,000
57,000
251,000
917,000
401,000
333,000
426,000
392,000
490,000
602,000
614,000
747,000
304,000
412,000
412,000304,000747,000614,000602,000490,000392,000426,000333,000401,000917,000251,00057,00046,00052,00044,00072,0001,00061,00063,00051,00033,468833,65927,99044,898
   > Long-term Assets 
0
0
889,291
1,301,104
3,461,562
3,414,000
8,143,000
7,900,000
7,687,000
7,326,000
7,238,000
7,472,000
7,538,000
6,771,000
6,855,000
6,965,000
6,827,000
6,469,000
6,761,000
7,786,000
9,737,000
10,500,000
12,564,000
12,095,000
12,559,000
12,559,00012,095,00012,564,00010,500,0009,737,0007,786,0006,761,0006,469,0006,827,0006,965,0006,855,0006,771,0007,538,0007,472,0007,238,0007,326,0007,687,0007,900,0008,143,0003,414,0003,461,5621,301,104889,29100
       Property Plant Equipment 
495,978
580,258
589,879
726,458
699,906
500,000
666,000
758,000
623,000
534,000
505,000
500,000
602,000
722,000
686,000
651,000
678,000
673,000
805,000
840,000
1,035,000
1,275,000
1,434,000
1,595,000
1,754,000
1,754,0001,595,0001,434,0001,275,0001,035,000840,000805,000673,000678,000651,000686,000722,000602,000500,000505,000534,000623,000758,000666,000500,000699,906726,458589,879580,258495,978
       Goodwill 
22,387
51,184
43,922
221,759
2,266,446
1,663,000
4,346,000
4,403,000
4,579,000
4,552,000
4,718,000
4,799,000
4,823,000
4,694,000
4,882,000
5,164,000
5,178,000
4,838,000
4,970,000
5,059,000
4,964,000
5,173,000
5,340,000
5,254,000
5,462,000
5,462,0005,254,0005,340,0005,173,0004,964,0005,059,0004,970,0004,838,0005,178,0005,164,0004,882,0004,694,0004,823,0004,799,0004,718,0004,552,0004,579,0004,403,0004,346,0001,663,0002,266,446221,75943,92251,18422,387
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
79,000
92,000
113,000
103,000
166,000
127,000
140,000
0
0
0
0
0
00000140,000127,000166,000103,000113,00092,00079,0000000000000000
       Intangible Assets 
96,750
96,566
254,829
462,960
595,071
721,000
2,537,000
2,293,000
2,169,000
1,953,000
1,641,000
1,525,000
1,483,000
1,336,000
1,242,000
1,078,000
898,000
840,000
893,000
5,898,000
7,937,000
8,332,000
10,156,000
4,232,000
4,082,000
4,082,0004,232,00010,156,0008,332,0007,937,0005,898,000893,000840,000898,0001,078,0001,242,0001,336,0001,483,0001,525,0001,641,0001,953,0002,169,0002,293,0002,537,000721,000595,071462,960254,82996,56696,750
       Long-term Assets Other 
0
0
44,583
111,686
2,166,585
354,000
484,000
106,000
155,000
65,000
79,000
63,000
48,000
-498,000
-682,000
-843,000
-953,000
-715,000
-760,000
-5,047,000
-4,952,000
-5,157,000
-5,300,000
41,000
277,000
277,00041,000-5,300,000-5,157,000-4,952,000-5,047,000-760,000-715,000-953,000-843,000-682,000-498,00048,00063,00079,00065,000155,000106,000484,000354,0002,166,585111,68644,58300
> Total Liabilities 
1,097,362
1,173,637
1,055,655
1,307,166
3,408,586
2,308,000
5,720,000
5,291,000
5,507,000
4,703,000
4,377,000
4,355,000
4,767,000
5,437,000
5,258,000
5,410,000
4,735,000
4,181,000
4,259,000
4,072,000
6,047,000
5,824,000
6,804,000
6,564,000
7,318,000
7,318,0006,564,0006,804,0005,824,0006,047,0004,072,0004,259,0004,181,0004,735,0005,410,0005,258,0005,437,0004,767,0004,355,0004,377,0004,703,0005,507,0005,291,0005,720,0002,308,0003,408,5861,307,1661,055,6551,173,6371,097,362
   > Total Current Liabilities 
718,016
724,931
727,685
744,129
2,791,317
707,000
1,521,000
1,886,000
2,554,000
2,062,000
1,853,000
1,612,000
1,808,000
2,345,000
2,605,000
3,061,000
2,418,000
1,949,000
2,152,000
2,394,000
2,814,000
2,824,000
3,112,000
2,616,000
3,529,000
3,529,0002,616,0003,112,0002,824,0002,814,0002,394,0002,152,0001,949,0002,418,0003,061,0002,605,0002,345,0001,808,0001,612,0001,853,0002,062,0002,554,0001,886,0001,521,000707,0002,791,317744,129727,685724,931718,016
       Short-term Debt 
0
0
127,994
98,354
2,020,000
31,000
65,000
532,000
989,000
566,000
-510,000
45,000
197,000
723,000
372,000
729,000
75,000
39,000
149,000
344,000
431,000
57,000
262,000
42,000
63,000
63,00042,000262,00057,000431,000344,000149,00039,00075,000729,000372,000723,000197,00045,000-510,000566,000989,000532,00065,00031,0002,020,00098,354127,99400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,750,000
194,000
707,000
25,000
37,000
111,000
268,000
396,000
17,000
222,000
1,000
2,000
2,0001,000222,00017,000396,000268,000111,00037,00025,000707,000194,0002,750,0000000000000000
       Accounts payable 
253,057
234,467
262,502
305,345
605,000
565,000
1,155,000
1,235,000
1,159,000
1,036,000
1,172,000
285,000
261,000
297,000
312,000
342,000
274,000
281,000
364,000
403,000
513,000
596,000
573,000
537,000
750,000
750,000537,000573,000596,000513,000403,000364,000281,000274,000342,000312,000297,000261,000285,0001,172,0001,036,0001,159,0001,235,0001,155,000565,000605,000305,345262,502234,467253,057
       Other Current Liabilities 
293,130
327,426
277,138
283,150
96,573
12,000
57,000
-35,000
319,000
232,000
97,000
1,138,000
1,182,000
1,091,000
1,722,000
1,248,000
1,635,000
1,460,000
1,457,000
1,428,000
1,583,000
1,817,000
1,976,000
1,833,000
2,552,000
2,552,0001,833,0001,976,0001,817,0001,583,0001,428,0001,457,0001,460,0001,635,0001,248,0001,722,0001,091,0001,182,0001,138,00097,000232,000319,000-35,00057,00012,00096,573283,150277,138327,426293,130
   > Long-term Liabilities 
0
0
327,970
563,037
617,269
1,601,000
4,199,000
3,405,000
2,953,000
2,641,000
2,524,000
2,743,000
2,959,000
2,015,000
1,738,000
1,650,000
1,591,000
1,531,000
1,287,000
1,678,000
3,233,000
3,000,000
3,692,000
3,948,000
3,789,000
3,789,0003,948,0003,692,0003,000,0003,233,0001,678,0001,287,0001,531,0001,591,0001,650,0001,738,0002,015,0002,959,0002,743,0002,524,0002,641,0002,953,0003,405,0004,199,0001,601,000617,269563,037327,97000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,585,000
1,574,000
1,534,000
1,350,000
975,000
0
0
0
0
0
00000975,0001,350,0001,534,0001,574,0001,585,000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
-127,994
-98,354
-2,020,000
-31,000
-65,000
-532,000
-989,000
-566,000
510,000
-45,000
-197,000
-723,000
-372,000
-729,000
-68,000
-34,000
-48,000
-245,000
-321,000
78,000
-122,000
119,000
143,000
143,000119,000-122,00078,000-321,000-245,000-48,000-34,000-68,000-729,000-372,000-723,000-197,000-45,000510,000-566,000-989,000-532,000-65,000-31,000-2,020,000-98,354-127,99400
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,000
0
0
0
0
1,000
0
0
1,000
1,000001,000000033,0000000000000000000
> Total Stockholder Equity
1,188,843
1,382,174
1,565,280
1,783,769
1,954,466
2,409,000
4,574,000
4,263,000
4,013,000
4,415,000
4,590,000
4,821,000
4,594,000
4,454,000
5,002,000
5,672,000
5,584,000
5,813,000
6,310,000
7,039,000
7,271,000
8,386,000
9,064,000
8,975,000
10,029,000
10,029,0008,975,0009,064,0008,386,0007,271,0007,039,0006,310,0005,813,0005,584,0005,672,0005,002,0004,454,0004,594,0004,821,0004,590,0004,415,0004,013,0004,263,0004,574,0002,409,0001,954,4661,783,7691,565,2801,382,1741,188,843
   Common Stock
437,799
437,799
437,799
437,799
437,799
438,000
2,148,000
2,151,000
2,151,000
2,151,000
550,000
2,151,000
2,151,000
550,000
584,000
584,000
584,000
584,000
584,000
584,000
584,000
584,000
584,000
584,000
584,000
584,000584,000584,000584,000584,000584,000584,000584,000584,000584,000584,000550,0002,151,0002,151,000550,0002,151,0002,151,0002,151,0002,148,000438,000437,799437,799437,799437,799437,799
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
-42,000
46,000
703,000
-10,000
-255,000
-356,000
-162,000
-413,000
-127,000
368,000
136,000
0
0136,000368,000-127,000-413,000-162,000-356,000-255,000-10,000703,00046,000-42,0000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,030,000
2,030,000
2,030,000
2,030,000
2,030,000
0
0
0
0
0
000002,030,0002,030,0002,030,0002,030,0002,030,000000000000000000
   Treasury Stock00000-377,000-342,000-357,000-283,000-295,000-173,000-168,000-239,000-262,000-125,000-125,000-125,000-127,000-124,000-95,00000000
   Other Stockholders Equity 
0
0
1,127,481
1,345,970
-309,000
-169,000
-124,000
-282,000
-412,000
-366,000
-125,000
-67,000
56,000
1,437,000
1,857,000
1,735,000
1,747,000
1,673,000
1,688,000
1,653,000
1,637,000
1,635,000
1,667,000
1,677,000
2,050,000
2,050,0001,677,0001,667,0001,635,0001,637,0001,653,0001,688,0001,673,0001,747,0001,735,0001,857,0001,437,00056,000-67,000-125,000-366,000-412,000-282,000-124,000-169,000-309,0001,345,9701,127,48100



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,152,000
Cost of Revenue-1,752,000
Gross Profit4,400,0004,400,000
 
Operating Income (+$)
Gross Profit4,400,000
Operating Expense-3,076,000
Operating Income1,324,0001,324,000
 
Operating Expense (+$)
Research Development1,781,000
Selling General Administrative272,000
Selling And Marketing Expenses2,075,000
Operating Expense3,076,0004,128,000
 
Net Interest Income (+$)
Interest Income29,000
Interest Expense-159,000
Other Finance Cost-10,000
Net Interest Income-140,000
 
Pretax Income (+$)
Operating Income1,324,000
Net Interest Income-140,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,163,0001,485,000
EBIT - interestExpense = 1,163,000
1,163,000
1,224,000
Interest Expense159,000
Earnings Before Interest and Taxes (EBIT)1,322,0001,322,000
Earnings Before Interest and Taxes (EBITDA)1,963,000
 
After tax Income (+$)
Income Before Tax1,163,000
Tax Provision-98,000
Net Income From Continuing Ops1,065,0001,065,000
Net Income1,065,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,828,000
Total Other Income/Expenses Net-161,000140,000
 

Technical Analysis of Ucb
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ucb. The general trend of Ucb is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ucb's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Ucb Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of UCB SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 172.95 < 180.90 < 193.76.

The bearish price targets are: 162.70 > 153.65 > 152.95.

Know someone who trades $UCB? Share this with them.👇

UCB SA Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of UCB SA. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

UCB SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of UCB SA. The current macd is 2.75552058.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ucb price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ucb. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ucb price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
UCB SA Daily Moving Average Convergence/Divergence (MACD) ChartUCB SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of UCB SA. The current adx is 18.58.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ucb shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
UCB SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of UCB SA. The current sar is 163.82.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
UCB SA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of UCB SA. The current rsi is 60.13. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
UCB SA Daily Relative Strength Index (RSI) ChartUCB SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of UCB SA. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ucb price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
UCB SA Daily Stochastic Oscillator ChartUCB SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of UCB SA. The current cci is 91.77.

UCB SA Daily Commodity Channel Index (CCI) ChartUCB SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of UCB SA. The current cmo is 23.84.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
UCB SA Daily Chande Momentum Oscillator (CMO) ChartUCB SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of UCB SA. The current willr is -28.87931034.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ucb is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
UCB SA Daily Williams %R ChartUCB SA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of UCB SA.

UCB SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of UCB SA. The current atr is 4.60421756.

UCB SA Daily Average True Range (ATR) ChartUCB SA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of UCB SA. The current obv is 18,568,565.

UCB SA Daily On-Balance Volume (OBV) ChartUCB SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of UCB SA. The current mfi is 61.72.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
UCB SA Daily Money Flow Index (MFI) ChartUCB SA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for UCB SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

UCB SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of UCB SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.130
Ma 20Greater thanMa 50165.745
Ma 50Greater thanMa 100162.050
Ma 100Greater thanMa 200164.228
OpenGreater thanClose172.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ucb with someone you think should read this too:
  • Are you bullish or bearish on Ucb? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ucb? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about UCB SA

I send you an email if I find something interesting about UCB SA.


Comments

How you think about this?

Leave a comment

Stay informed about UCB SA.

Receive notifications about UCB SA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.